80 likes | 94 Views
Structural Heart Devices Market is driven by rise in the number of transcatheter aortic valve replacement procedures across the globe and new product launches by key players.
E N D
Structural Heart Devices Market Product: Biological/Tissue Valves, Mechanical Heart Valves, Annuloplasty Rings, Occluders, and Accessories; Procedure: Replacement Procedures and Repair Procedures; Indication: Valve Stenosis, Valve Regurgitation, Cardiomyopathy, Congenital Heart Defects, and Others & Forecast, 2019 - 2027 1
Table of Content: Sr. No. Content Chapter 1 Preface Chapter 2 Assumptions and Research Methodology 12 Chapter 3 Executive Summary 10 Chapter 4 Market Overview Chapter 5 Market Outlook 8 Chapter 6 Global Structural Heart Devices Market Analysis and Forecast, by Type Column 1 Column 2 Column 3 Chapter 7 Global Structural Heart Devices Market Analysis and Forecast, by Therapy 6 Chapter 8 Global Structural Heart Devices Market Analysis and Forecast, by Region 4 Chapter 9 North Structural Heart Devices Market Analysis and Forecast Chapter 10 Europe Structural Heart Devices Market Analysis and Forecast 2 Chapter 11 Asia Pacifc Structural Heart Devices Market Analysis and Forecast Chapter 12 Latin America Structural Heart Devices Market Analysis and Forecast 0 Row 1 Row 2 Row 3 Row 4 Chapter 13 Middle East & Africa Structural Heart Devices Market Analysis and Forecast Chapter 14 Competition Landscape Access Full TOC 2
Report Highlights: ●The global structural heart devices market is projected to expand at a CAGR of 7.5% from 2019 to 2027 and to Reach a Value of ~US$ 13 Bn by 2027. ●The high cost of minimally-invasive procedures is projected to hamper the growth of the global structural heart devices market. ●Key players operating in the global structural heart devices market are Medtronic, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical, Micro Interventional Devices, Inc., Lifetech Scientific, Neovas, and CryoLife, Inc. ●The structural heart devices market in Asia Pacific is expected to expand at a high CAGR of ~8% from 2019 to 2027 Request Brochure of Report 3
Continue.. ●Based on indication, the global structural heart devices market has been categorized into valve stenosis, valve regurgitation, cardiomyopathy, congenital heart defects, and others. ●In terms of region, the global structural heart devices market has been segmented into North America, Europe, Latin America, Asia Pacifc, and the Middle East & Africa. ●The structural heart devices market in Europe is expected to expand at a considerable CAGR in the near future, due to signifcant increase in the number of biological/tissue heart valves receiving CE marks and the rapid adoption of technologically-advanced structural heart devices for the treatment of valvular heart diseases. Request Sample of Report 5
Contact Us Mr. Rohit Bhisey Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ 7